New research has demonstrated the key role two proteins play in the development of multiple sclerosis (MS). The study found that the onset of MS could be slowed down or even halted if the proteins were blocked.
The protein identified contributed to nerve damage, including numbness, blindness, difficulties with speech and cognitive impairments in sufferers. When the proteins were blocked however, the progression of the disease was halted.
MS affects more than 20,000 people in Australia and this study could lead to new treatments for MS.
Read more at Monash University